Matthew 25 Management Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.4M Sell
24,500
-3,000
-11% -$3.07M 8.51% 3
2026
Q1
$25.3M Buy
27,500
+2,000
+8% +$2.03M 8.4% 3
2025
Q4
$27.4M Buy
25,500
+10,000
+65% +$9.56M 8.38% 4
2025
Q3
$11.8M Buy
15,500
+8,250
+114% +$6.14M 3.64% 13
2025
Q2
$5.65M Buy
+7,250
New +$5.63M 1.82% 17

Other funds holding LLY

Matthew 25 Management Corp's LLY Position: Q2 2026 in Review

Matthew 25 Management Corp reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $3.07M and leaving 24,500 shares worth $29.4M. The position accounts for 8.51% of the portfolio, ranked #3.

Matthew 25 Management Corp first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Matthew 25 Management Corp held 24,500 shares of Eli Lilly worth $29.4M as of Q2 2026.
  • Matthew 25 Management Corp sold 3,000 Eli Lilly shares in Q2 2026, an estimated $3.07M.
  • Eli Lilly made up 8.51% of Matthew 25 Management Corp's portfolio in Q2 2026, its #3 holding.
  • Matthew 25 Management Corp first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Matthew 25 Management Corp's 13F filing for Q2 2026, filed 14 Aug 2026.